Details for Patent: 11,219,621
✉ Email this page to a colleague
Which drugs does patent 11,219,621 protect, and when does it expire?
Patent 11,219,621 protects XOLREMDI and is included in one NDA.
This patent has thirty-four patent family members in eleven countries.
Summary for Patent: 11,219,621
Title: | Methods for treating immunodeficiency disease |
Abstract: | The present invention relates to methods of treating patients with WHIM syndrome or related disorders, such as myelokathexis, in which X4P-001 is administered in order to reduce the activity of CXCR4. The methods demonstrate surprising effectiveness, with comparatively little toxicity. |
Inventor(s): | Arbeit Robert D., Ragan Paula Marie |
Assignee: | X4 Pharmaceuticals, Inc. |
Application Number: | US16804863 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,219,621
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X4 Pharms | XOLREMDI | mavorixafor | CAPSULE;ORAL | 218709-001 | Apr 26, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PATIENTS 12 YEARS AND OLDER WITH WARTS, HYPOGAMMAGLOBULINEMIA, INFECTIONS, AND MYELOKATHEXIS (WHIM) SYNDROME | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,219,621
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 3008272 | ⤷ Sign Up | |||
Canada | 3008279 | ⤷ Sign Up | |||
Canada | 3009176 | ⤷ Sign Up | |||
Canada | 3010617 | ⤷ Sign Up | |||
China | 108883091 | ⤷ Sign Up | |||
China | 108883132 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |